Medicine and Dentistry
Psoriasis
100%
Patient
47%
Disease
34%
COVID-19
32%
Meta-Analysis
32%
Biological Marker
30%
Therapeutic Procedure
26%
Association
25%
Treatment Response
20%
Immunity
19%
Pustulosis Palmaris Et Plantaris
17%
Analysis
17%
Systemic Therapy
16%
Acneiform Eruption
16%
Clinical Feature
16%
UK Biobank
15%
Drug
12%
Inflammatory Disorder
11%
Pustular Psoriasis
10%
Immunomodulating Agent
10%
Cohort Analysis
10%
Biological Therapy
9%
Cross Sectional Study
9%
Atopic Dermatitis
8%
Therapeutics
8%
Ustekinumab
8%
TNF Inhibitor
8%
Dermatosis
8%
Monotherapy
8%
Pathogenesis
8%
Disease Exacerbation
8%
Generalized Pustular Psoriasis
8%
Cytotechnology
8%
Urticaria
8%
Keloid
8%
Hypertrophic Scar
8%
Genotype
8%
Hair Follicle
8%
Ovary Follicle Development
8%
Mediator
8%
Genetic Risk
8%
Genetic Difference
8%
Cohort Study
8%
Adalimumab
8%
Physician
7%
Genome Wide Association Study
7%
Woman
6%
Cohort Effect
6%
Age
6%
Health Care Cost
5%
Biochemistry, Genetics and Molecular Biology
Genetics
45%
Gene
38%
Heritability
18%
Genomics
16%
Exome Sequencing
16%
Genetic Heterogeneity
16%
Genetic Divergence
13%
Protein
13%
Exome
12%
Genotyping
11%
Genetic Architecture
10%
Amino Acids
9%
Waist Circumference
9%
Clinical Trial
8%
Major Histocompatibility Complex
8%
Folliculogenesis
8%
Gene Signature
8%
Association Mapping
8%
Epidermolysis bullosa
8%
Genetic Predisposition
8%
Comparative Genomics
8%
Interferon Type I
8%
Mast Cell
8%
IL1B
8%
Complement Factor B
8%